Migraleve
Oxford A-Z of Medicinal Drugs:
Top
Migraleve
Manufactured by McNeil Ltd
A proprietary preparation consisting of a combination of the analgesics paracetamol and codeine phosphate and the antiemetic antihistamine buclizine hydrochloride in the form of pink tablets, packaged with a combination of paracetamol and codeine phosphate (yellow tablets), used for the treatment of migraine. Two pink tablets taken at the start of a migraine attack are followed by two yellow tablets at four-hourly intervals. Migraleve can be obtained without a prescription, but only from pharmacies.
Side effects:
Migraleve causes drowsiness.
Precautions:
Migraleve should not be taken by children under 10 years old, except under medical supervision. See also paracetamol; antihistamines.
Interactions with other drugs:
see antihistamines; opioids.
| Migraine Relief, MigraMax, Midrid | |
| Migril, Milpar, Minims Artificial Tears |
Wikipedia on Answers.com:
Top
Migraleve
Migraleve is the brand name of a range of migraine-relief medications made by Pfizer.
There are two variants of Migraleve: Yellow and pink, which all contain the analgesics paracetamol and codeine. The yellow variant is designed to address the symptoms of headache and discomfort, whilst the pink variant also addresses symptoms of nausea and vomiting. Recently, a third Migraleve variant was released, Migraleve Ultra, which contains sumatriptan.
The pink tablet is supposed to be taken before the yellow tablet. [1]
|
Contents
|
Migraleve Yellow
The active ingredients of Migraleve Yellow are:
- paracetamol DC 96% 520 mg equivalent to paracetamol 500 mg and codeine phosphate 8 mg.
Other ingredients: magnesium stearate, colloidal anhydrous silica, stearic acid, pregelatinised maize starch, gelatin, hypromellose, macrogol, E104 (quinoline yellow), aluminium oxide, E171 (titanium dioxide) and E172 (iron oxide yellow).
Migraleve Pink
The active ingredients of Migraleve Pink are:
- paracetamol DC 96% 520 mg equivalent to paracetamol 500 mg, codeine phosphate 8 mg and buclizine hydrochloride 6.25 mg.
Other ingredients: magnesium stearate, colloidal anhydrous silica, stearic acid, pregelatinised maize starch, gelatin, hypromellose, macrogol, E127 (erythrosine), aluminium oxide and E171 (titanium dioxide).
Migraleve Ultra
The active ingredient of Migraleve Ultra is 50 mg sumatriptan, similar to Imigran recovery.
License and manufacture
The Product Licence Holder is: Pfizer Consumer Healthcare, Walton-on-the-Hill, Surrey, KT20 7NS [2]
The manufacturer is: Gödecke GmbH, Mooswaldallee 1, 79090, Freiburg, Germany.
References
- ^ "Products". Migraleve.co.uk. 2010-03-26. http://www.migraleve.co.uk/products.aspx. Retrieved 2010-12-07.
- ^ "Pfizer official website". http://www.pfizer.com.
External links
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
Post a question - any question - to the WikiAnswers community:
Copyrights:
Oxford A-Z of Medicinal Drugs
Market University Press. © 2000, 2003, 2010 An A-Z of Medicinal Drugs. All rights reserved.
Read more
